Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Research award to advance breast cancer treatments

Research award to advance breast cancer treatments

Date time 10 September, 2024
News Type News type Media release
Dr Mark Schreuder, a researcher at the Centenary Institute’s Centre for Cancer Innovations, has received the Kenyon Foundation Inflammation Award for 2024.

Valued at $20,000, the award will fund Dr Schreuder’s investigation into a new imaging technology designed to measure tumour cell death, with a specific focus on its application in breast cancer.

A leading cause of cancer-related deaths among Australian women, breast cancer claims over 3,200 lives in Australia each year.

Dr Schreuder’s study will evaluate the effectiveness of an innovative agent called Cell Death Indicator (CDI) that is used in combination with standard PET scans. This new imaging technique, known as CDI-PET, enables precise identification of dying and dead tumour cells. CDI-PET will be tested in mouse models of breast cancer to see how well it works in showing the effects of cancer treatments.

Dr Schreuder said the research addresses a significant challenge in diagnosing and monitoring breast cancer.

“Currently, imaging methods have a hard time distinguishing the difference between tumour cells and surrounding inflammation, especially after treatments like radiation or immunotherapy. This makes it tough to accurately assess how well the treatment is working and can introduce uncertainty about what to do next,” said Dr Schreuder.

“With CDI-PET, our goal is to give clinicians a much clearer picture of the tumour and the effectiveness of the treatments taking place. This clarity can help optimise and better personalise treatment plans for patients, allowing for quicker switches to alternative therapies when required or reducing unnecessary treatments,” he said.

Mr David Kenyon AM, Trustee of the Kenyon Foundation, underscored the importance of supporting such ground-breaking research.

“Breast cancer impacts countless lives in Australia every year. We are proud to support Dr Schreuder’s pioneering work, which holds the promise of driving positive change and improving outcomes in this vital area of healthcare,” said Mr Kenyon.

Dr Schreuder said that CDI-PET could potentially lead to more personalised and efficient treatments not only for breast cancer but for other types of cancer as well.

Themes

  • Cancer Innovations

    Cancer Innovations

Media enquires

For all media and interview enquiries, please contact Alison Mendel

Phone number Phone Number +61 434 629 469

Email Email a.mendel@centenary.org.au

Media Release

Research award to advance breast cancer treatments

Download

Recent Stories

  • New platform to evolve proteins for better therapies

    Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.
    News Type: Media release
    Date 08 May 2025
  • Turning off protein may help prevent liver cancer

    New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.
    News Type: Media release
    Date 16 Apr 2025
  • Event shines spotlight on genetic heart disease in young people

    The Centenary Institute has hosted a community event, titled ‘A Needle in a Haystack: Unlocking the Secrets of Genetic Heart Conditions’. The event aimed to advance understanding of inherited heart disease and sudden cardiac death in young people.
    News Type: Community
    Date 10 Apr 2025
  • Finding answers for sudden cardiac death in young people

    Each week in Australia, up to three young people die suddenly and unexpectedly from sudden cardiac death, often due to an undiagnosed genetic heart condition. These conditions typically go unnoticed until tragedy strikes, leaving families devastated and searching for answers.
    News Type: Media release
    Date 02 Apr 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram